Stallion India Fluorochemicals IPO Proceeds Monitoring Report Q4 FY26
Stallion India Fluorochemicals Ltd has submitted its Monitoring Agency Report for the quarter ended June 30, 2026, detailing the utilization of its IPO proceeds amounting to ₹160.73 crore. The report, issued by CARE Ratings Limited, indicates no material deviations from the objects disclosed in the Offer Document. While there were initial deviations in 'Issue expenses' and 'purchase of land' versus 'construction of warehouse', these have been addressed and approved by shareholders through Special Resolutions. The company has revised its fund allocation for issue expenses and adjusted capital expenditure plans, with excess utilization within the 10% threshold for certain objects. The report confirms that necessary shareholder approvals have been obtained for revised cost allocations and object modifications.
Key Highlights
- IPO proceeds utilization report for Q4 FY26 submitted by Stallion India Fluorochemicals.
- No material deviations found in IPO proceeds utilization as per CARE Ratings.
- Shareholder approvals obtained for revised fund allocation and object changes.
- Initial deviations in issue expenses and land purchase were addressed and approved.
- Utilization remains within the 10% deviation range for specified objects.
Price Impact
More from STALLION
Stallion India Fluorochemicals PAT Surges 79% to ₹18.57 Crore in Q1 FY27
Stallion India Q1 FY27: standalone PAT jumps 79% YoY to ₹18.6 Cr as margins expand sharply
Stallion India Fluorochemicals Board Meeting on Aug 12, 2026